Topics and Expertise: pharmacogenetics

The UCSF Asthma Collaboratory celebrates 20 years of research on genetic factors in asthma.

Vice Provost-Academic Affairs

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.

Studies of pharmacogenetics testing of pharmacy students as a teaching tool, an improved system to resolve medication issues after patients go home from the hospital, and the prophylactic use of an antiseizure drug for brain surgery patients took top honors at the Department of Clinical Pharmacy...

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescription drugs against key molecules in the liver and kidney that are responsible for...

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at ACCP's annual meeting.

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how genes affect an...

Deanna Kroetz, PhD, UCSF School of Pharmacy faculty member, has been elected as a fellow of the American Association of Pharmaceutical Scientists (AAPS). Her election was announced during the November 2008 annual AAPS meeting in Atlanta, Georgia.